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Cancer is currently responsible for more than 7 million deaths 
per year worldwide, more than malaria, tuberculosis and 
HIV/AIDS combined. There are more than 600 000 deaths 
annually in Africa from cancer.  In the developing world, the 
number of new cancer cases will increase significantly over the 
next 10 years. By 2020 there are expected to be 15 million new 
cases of cancer every year, 70% of which will be in developing 
countries, where governments are least prepared to address the 
growing cancer burden and where survival rates are often less 
than half those in more developed countries. African countries 
will account for over a million new cancer cases a year and 
they are the least able of all developing countries to cope, 
having fewest cancer care services.
Currently the world is focused on controlling the spread 
of HIV, TB and malaria, which are all acknowledged to be 
major killers in the developing world. Huge sums of money 
are currently available to help combat these diseases. Cancer 
is set to become the newest epidemic in the developing world, 
claiming a vast number of lives, and there is currently limited 
funding available to tackle this disease. Raising awareness 
of this looming epidemic in Africa is the first step. If we take 
concerted action now, we can prevent another tragedy. 
A meeting on Cancer Control in Africa was held on 10 - 11 
May 2007 in London to raise awareness of the growing cancer 
epidemic in Africa and to determine how best to deliver 
comprehensive cancer care to Africa.  A new organisation 
(AfrOx) set up by Professor D Kerr, Oxford University, 
organised the meeting.
Over 130 delegates attended the meeting, which was held 
in London’s Reform Club.  Twenty African countries (Benin, 
Botswana, Burkina Faso, Cameroon, Cape Verde, Egypt, Gabon, 
The Gambia, Ghana, Lesotho, Libya, Malawi, Mauritius, 
Morocco, Mozambique, Nigeria, Rwanda, Sierra Leone, South 
Africa and Zambia) and the Yemen were represented at the 
meeting by their Ministers of Health, their representatives, or 
their leading oncologists. In addition, representatives from 
major national and international health care and cancer-related 
charities and organisations including representatives of the 
pharmaceutical industry, the World Health Organization, the 
World Bank, the International Agency for Research on Cancer 
(IARC) and the African Development Bank, members of the 
UK parliament, African doctors and health care workers 
attended the meeting, together with leading oncologists from 
the RSA, UK, USA, France, Netherlands, Ireland, Sweden, 
Norway and India.
The aims of the meeting were to: (i) determine the degree of 
priority cancer is afforded in national programmes in Africa; 
(ii) determine the most affordable and effective components of 
cancer control; (iii) decide on a clear implementation strategy 
for bringing these programmes to African countries; (iv) design 
mentorship and training programmes for African health care 
workers and scientists, and engage the support of Oxford 
University and the international cancer care community to 
run these programmes; and (v) identify a strategy to raise the 
necessary funds to enable implementation of the cancer control 
programmes. 
The African health ministers and their representatives 
who presented at the meeting stated unanimously that 
they recognise the explosion in cancer incidence and would 
welcome the support of the international oncology community 
in tackling the growing cancer epidemic, but that in order to 
deliver comprehensive cancer control to Africa effectively we 
must integrate with existing programmes that are tackling 
AIDS, malaria and TB.
This is the first collective and definitive statement by a 
representative cross-section of African health ministries of the 
urgent need to initiate cancer control programmes. It lays to 
rest the myth that the only health priorities in Africa are those 
related to infectious diseases and that care of chronic diseases 
is best integrated with existing programmes.
In Africa, it is thought that up to a third of cancer deaths 
are potentially preventable. In 2002 in sub-Saharan Africa, 
there were more than half a million cancer deaths, of which 
almost 40% can be explained by chronic infection and tobacco 
usage. Chronic infection with the hepatitis virus increases the 
risk of liver cancer, infection with HIV increases the risk of 
Kaposi’s sarcoma, and chronic infection with certain types of 
human papillomavirus increases the risk of cervical cancer. 
Today we have vaccines to protect against hepatitis B and 
human papillomavirus infection, but they are not available 
in the countries that need them most. Tobacco use is the most 
preventable cause of death. Unless we see concerted action to 
establish cancer prevention programmes (vaccination, anti-
smoking measures, etc.) to reduce the number of cancer cases, 
the limited treatment facilities that exist in the majority of 
African countries will be completely overwhelmed by an ever-
expanding cancer burden.
Lack of resources and basic infrastructure mean that 
most Africans have no access to cancer screening, early 
diagnosis, treatment or palliative care. While there have been 
some improvements in recent years (in 1991 there were 63 
radiotherapy machines and currently there are over 200), 
radiotherapy is available in only 21 of Africa’s 53 countries, 
reaching less than 5% of the population, and consequently 
patients are denied a treatment that can be life-saving and 
significantly improve cancer pain. 
Some of the startling findings at the London meeting 
included: (i) cancer sufferers, when diagnosed, face 
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stigmatisation in many African countries; (ii) a diagnosis of 
cancer is equated with an inescapable and painful death; and 
(iii) the majority of attending nations have no elements of a 
cancer plan.
The main output from the meeting was the London 
Declaration on Cancer Control in Africa (see www.afrox.org), 
a document that aims to raise awareness of the magnitude of 
the cancer burden in Africa and to call for immediate action to 
bring comprehensive cancer care to African countries. 
It builds on the World Health Assembly Resolution on 
Cancer Prevention and Control (2005) and on previous 
declarations from the International Atomic Energy Agency 
(Cape Town Declaration on Cancer Control in Africa, 
December 2006) and the International Union Against Cancer 
(World Cancer Declaration, July 2006).
There was complete agreement among delegates that 
the only way effectively to prevent, detect and treat the 
rising numbers of cancers in Africa is to develop broad 
partnerships between local health care delivery systems, 
research institutions, international organisations, national 
governments in developed and developing countries, and 
the pharmaceutical industry.  Strong local and international 
leadership is essential. The relevant organisations and 
individuals, with funds from government and private 
donors, must be brought together to develop achievable and 
sustainable national cancer plans that are evidence based, 
priority driven and resource appropriate for African countries.
Delegates also agreed that the introduction of cancer care 
into African countries requires integration of clinical and 
public health systems so that they become truly comprehensive 
and bring together prevention, early diagnosis, treatment, 
palliative care and the investment needed to deliver these 
services in terms of trained staff, equipment, relevant drugs 
and information systems. However, any cancer control strategy 
must be guided by the needs of the country and must be 
resource appropriate for that country.
We believe that we have a timely opportunity to develop 
a sustainable model for developing comprehensive cancer 
care to African countries, authored by the member states and 
with technical, policy and financial support provided by inter-
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